Adoptive transfer of CXCR3+ TH17 cells into mice with experimental NAFLD increased hepatic damage compared with those given CXCR3− TH17 cells [148]. This evidence concerns the gene CXCR3 and metabolic dysfunction-associated steatotic liver disease.